Moves to trading on the Primary Market of the American Stock Exchange Sept. 24 under the symbol "EDI." The firm met listing requirements through recent private placements of approximately $1 mil. The Burlington, North Carolina firm, which had traded on the Emerging Company Marketplace, recently signed a letter of intent to acquire drug testing firm PDLA.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights